Przejdź do zawartości
Merck
  • Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp.

Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp.

The Journal of dermatological treatment (2013-04-06)
Stanislaw A Buechner
ABSTRAKT

This study investigated the non-inferiority of efficacy and tolerance of 2% miconazole nitrate shampoo in comparison with 2% ketoconazole shampoo in the treatment of scalp seborrheic dermatitis. A randomized, double-blind, comparative, parallel group, multicenter study was done. A total of 274 patients (145 miconazole, 129 ketoconazole) were enrolled. Treatment was twice-weekly for 4 weeks. Safety and efficacy assessments were made at baseline and at weeks 2 and 4. Assessments included symptoms of erythema, itching, scaling ['Symptom Scale of Seborrhoeic Dermatitis' (SSSD)], disease severity and global change [Clinical Global Impressions (CGIs) and Patient Global Impressions (PGIs)]. Miconazole shampoo is at least as effective and safe as ketoconazole shampoo in treating scalp seborrheic dermatitis scalp.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Miconazole, European Pharmacopoeia (EP) Reference Standard
USP
Azotan mikonazolu, United States Pharmacopeia (USP) Reference Standard
Miconazole nitrate, European Pharmacopoeia (EP) Reference Standard
Supelco
(±)-Miconazole nitrate salt, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
(±)-Miconazole nitrate salt, imidazole antibiotic